Aggregation of marginal gains in cardiac surgery:feasibility of a perioperative care bundle for enhanced recovery in cardiac surgical patients by Fleming, Ian et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1053/j.jvca.2016.01.017
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Fleming, I., Garratt, C., Guha, R., Desai, J., Chaubey, S., Wang, Y., ... Kunst, G. (2016). Aggregation of
marginal gains in cardiac surgery: feasibility of a perioperative care bundle for enhanced recovery in cardiac
surgical patients. Journal of Cardiothoracic and Vascular Anesthesia, 30(3), 665–670.
10.1053/j.jvca.2016.01.017
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
Aggregation of Marginal Gains in Cardiac Surgery:
Feasibility of a Perioperative Care Bundle for
Enhanced Recovery in Cardiac Surgical Patients
Ian O. Fleming, FRCA,* Claire Garratt, FRCA,* Ranj Guha, FRCA,* Jatin Desai, FRCS (C.Th.),†
Sanjay Chaubey, MRCS,† Yanzhong Wang, PhD,‡ Sara Leonard, FRCA, FFICM,*§ and
Gudrun Kunst, MD, PhD, FRCA, FFICM*
Objectives: The aim of this pilot study was to assess the
feasibility of a perioperative care bundle for enhanced
recovery after cardiac surgery (ERACS).
Design: A prospective, observational study.
Setting: A major urban teaching and university hospital
and tertiary referral center.
Participants: The study included 53 patients undergoing
cardiac surgery before implementation of an ERACS protocol
(pre-ERACS group) and 52 patients undergoing cardiac surgery
after implementation of an ERACS protocol (ERACS group).
Interventions: Based on recommendations from a consen-
sus review in colorectal surgery, the following enhanced
recovery perioperative care bundle was applied: detailed
preoperative information, avoidance of prolonged fasting
periods preoperatively, preoperative carbohydrate bever-
ages, optimization of analgesia with avoidance of long-
acting opioids, prevention of postoperative nausea and
vomiting, early enteral nutrition postoperatively, and early
mobilization.
Measurements and Main Results: The authors hypothe-
sized that length of hospital stay would be reduced with
ERACS. Secondary outcome variables included a composite of
postoperative complications and pain scores. Whereas the
length of stay in the group of patients receiving the bundle
of enhanced recovery interventions remained unchanged
compared with the non-ERACS group, there was a statistically
signiﬁcant reduction in the number of patients in the ERACS
group presenting with one or more postoperative complica-
tions (including hospital-acquired infections, acute kidney
injury, atrial ﬁbrillation, respiratory failure, postoperative myo-
cardial infarction, and death). In addition, postoperative pain
scores were improved signiﬁcantly in the ERACS group.
Conclusions: This pilot study demonstrated that ERACS is
feasible and has the potential for improved postoperative
morbidity after cardiac surgery. A larger multicenter quality
improvement study implementing perioperative care bun-
dles would be the next step to further assess outcomes in
ERACS patients.
& 2016 The Authors. Published by Elsevier Inc. All rights
reserved.
KEY WORDS: cardiac surgery, perioperative quality
improvement bundles, enhanced recovery, postoperative
morbidity
PROFOUND CHANGE HAS occurred during the last 2decades, with enhanced recovery principles becoming
embedded in the perioperative care of patients across a range of
surgical specialties. These have challenged and reshaped tradi-
tional models of hospital care.1,2 Favorable outcome data, coupled
with political and economic drivers to improve efﬁciency in
healthcare delivery, have resulted in increasingly diverse applica-
tions of such practice.3 Recently, enhanced recovery pathways
have been proposed for related “high-risk” specialties, such as
thoracic surgery,4 yet few published data relate to enhanced
recovery after cardiac anesthesia and surgery. With reference to
published literature on the perioperative management of patients
undergoing enhanced recovery care, the authors proposed speciﬁc
enhanced recovery interventions that may be suitable for cardiac
surgery patients. The authors report on a prospective pilot and
feasibility study and how a bundle of perioperative evidence-
based enhanced recovery implementations has demonstrated the
potential of improved postoperative outcomes.
The “aggregation of marginal gains” is a concept popularized
by Sir David Brailsford, a British cycling coach whose teams
achieved astonishing success while competing at recent Olympic
Games and the Tour de France. The notion involves ﬁnding and
exploiting small margins for improvement at every stage. In
healthcare, innovation through the adoption of enhanced recov-
ery pathways has resulted in performance improvement through
similar means. Elimination of small, apparently insigniﬁcant
imperfections in patient care provides cumulative beneﬁt and
contributes to improved overall outcome.
“Enhanced recovery after surgery” (ERAS), or “fast-track
surgery,” is a multimodal, evidence-based pathway devised to
optimize the perioperative care of surgical patients. ERAS ﬁrst
became established in colorectal surgery almost 20 years ago,
after pioneering work by Henrik Kehlet.1,2 Compelling evi-
dence has demonstrated that bundles of evidence-based best
practice, delivered by a multidisciplinary team throughout the
perioperative process, lead to an earlier return to preoperative
physiologic functions after surgery than do traditional methods.
Key outcomes include improved patient satisfaction and cost-
effectiveness, with reduced morbidity and length of hospital
stay. These reﬁnements have led to ERAS becoming the
standard of care in many European countries for patients
undergoing colorectal surgery, with an expansion of its role
to other surgical specialties, and from elective to emergency
care.5
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Overall, 36,100 cardiac surgical procedures were performed
in the United Kingdom in 2013.6 The predicted risk of patients
undergoing such procedures has increased, yet in-hospital
mortality from cardiac surgery has fallen from 3.7% to 2.7%
in the last decade. Morbidity after cardiac surgery remains
variable, however, with postoperative incidences of myocardial
infarction of up to 22%,7 delirium of 46%,8 and acute kidney
injury (AKI) of up to 30%.9 Quality improvements including
evidence-based perioperative enhanced recovery bundles may
further reduce perioperative morbidity. Improved patient out-
comes and utilization of resources with perioperative enhanced
recovery bundles may yield substantial economic savings and
increase institutional productivity.10 The current literature
suggests that specialties such as thoracic surgery have
embraced enhanced recovery pathways, mainly through extrap-
olation of data obtained from patients undergoing colorectal
surgery.4 There remains, however, a comparative paucity of
literature and, therefore, potentially a lack of clinical applica-
tion, of enhanced recovery techniques in cardiac patients, with
a resultant need to develop similar pathways tailored to these
patients.
To evaluate the feasibility and outcome of enhanced
recovery after cardiac surgery (ERACS), the authors’ institu-
tion undertook a pilot and feasibility study, prospectively
comparing a pre-ERACS group with an ERACS group. The
authors hypothesized that an enhanced recovery pathway in
cardiac surgery (including optimization of preoperative fasting
and high-energy drinks, perioperative analgesia, and postoper-
ative mobilization) implemented through perioperative bundles
would reduce length of stay (primary objective) and improve
perioperative outcome variables (secondary objectives).
METHODS
This study received institutional approval by King’s College
Hospital NHS Foundation Trust (audit project number
AP1161-01).
Data were collected prospectively at a major urban teaching
hospital and tertiary referral center for all patients undergoing
cardiac surgery during October 2010 for the control group
before implementation of the ERACS protocol (pre-ERACS
group) and by the same team during July 2011 after imple-
mentation of the ERACS protocol (ERACS group). All adult
patients scheduled for elective cardiac surgery, including coro-
nary artery bypass graft (CABG) surgery, aortic valve replace-
ment (AVR), and mitral valve and aortic root surgery—and
different combinations of these cardiac surgical procedures—as
well as redo cardiac surgeries, were included in the study.
Patients undergoing emergency surgery or thoracic procedures
were excluded. Data collection took place during patient inter-
views postoperatively and from review of patient notes and
electronic drug charts.
The following departmental methods were part of the
induction and maintenance of general anesthesia. On arrival
to the operating room, all patients received intravenous mid-
azolam (0.02-0.05 mg/kg) before induction of general anes-
thesia, and an arterial cannulae was inserted. Induction of
anesthesia included analgesia with fentanyl (3-5 mg/kg),
hypnosis with propofol, 1 to 2 mg/kg, and muscle relaxation
with atracurium, 0.5 to 0.7 mg/kg. Thereafter, the trachea was
intubated and mechanical ventilation started. A central catheter
was placed in the right internal jugular vein, and a trans-
esophageal echocardiography (TEE) probe was placed in the
esophagus of most patients. Anesthesia was maintained with a
1-to-1.25 minimal anesthetic concentration (about 1.15-1.5 vol%
of end-tidal isoﬂurane) that continued during bypass, or with a
propofol infusion during bypass. Analgesia was maintained
with fentanyl or morphine boluses and/or remifentanil infu-
sions. Monitoring included continuous arterial blood pressure,
central venous pressure, leads I and V5 of the electrocardio-
gram, and nasopharyngeal temperature. TEE monitoring
included assessments of left/right ventricular ﬁlling and myo-
cardial contractility. Volume and inotropes were given to
optimize preload, afterload, and myocardial contractility. Car-
dioprotection during cardiopulmonary bypass was provided by
mild hypothermia (321C in the majority of cases) and by
intermittent cold blood St Thomas’ cardioplegia, which was
administered anterogradely, after cross-clamping of the aorta,
via the aortic root into the coronary arteries. After cardiopul-
monary bypass was discontinued, protamine was administered
to reverse the heparin.
Based on recommendations from a consensus review in
colorectal surgery,11 the authors identiﬁed the following
enhanced recovery interventions that could be applied to all
cardiac surgical patients: detailed preoperative information for
patients (including anesthesia and perioperative ﬂuid intake),
avoidance of prolonged fasting periods preoperatively, preop-
erative carbohydrate beverages,12,13 optimization of analge-
sia,14 avoidance of long-acting opioids, prevention and
treatment of postoperative nausea and vomiting, early enteral
nutrition postoperatively, and early mobilization. ERAS has its
greatest evidence base in colorectal surgery; nevertheless, most
of these interventions are general in nature and therefore
applicable not only in colorectal surgery but also in other
surgical specialties.
The detailed protocol for ERACS with preoperative and
postoperative bundles is shown in Table 1. Over a period of 4
weeks, medical teams on cardiac wards received weekly
teaching by dedicated cardiac practice development nurses
about the preoperative bundle. The postoperative bundle of
interventions was taught on the postoperative cardiac recovery
unit and on cardiac high-dependency units.
The length of hospital stay was recorded, and during daily
postoperative follow-up visits, a composite of postoperative
complications occurring within the ﬁrst postoperative week
also were recorded. These included new-onset atrial ﬁbrillation
requiring medical treatment; AKI (with a raised creatinine level
of more than 30% from the preoperative level); respiratory
failure (new postoperative requirements of oxygen via face
mask or of noninvasive or invasive respiratory support);
myocardial infarction (new pathologic Q-waves or new left
bundle-branch block on the electrocardiogram, angiographi-
cally documented new graft or native coronary artery occlu-
sion, or imaging evidence of new loss of viable myocardium
plus biomarker values above 5 times the 99th percentile of the
normal reference range); stroke (new neurologic deﬁcit);
hospital-acquired infections or sepsis (requiring prolonged
postoperative antibiotics for more than the usual 3
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postoperative days, including postoperative infections such as
surgical site infections or respiratory tract infections, accom-
panied by prolonged increased white cell count or C-reactive
protein levels requiring microbiologic review); and death.
Apart from patients’ demographics, perioperative variables
included preoperative fasting times (solids and liquids) and
perioperative anesthetic and surgical details. In addition, pain
scores at rest on postoperative days 1 to 3 (0, no pain; 1, mild
pain; 2, moderate pain; 3, severe pain), nausea and vomiting,
time to ﬁrst bowel movement, mobilization (time to ﬁrst sitting
in chair), inotropes, and postoperative drugs (prescriptions,
actually given) were collected from individual case report forms.
Statistical Analysis
Continuous variables were summarized as mean with stand-
ard deviation (SD) or median with interquartile range (IQR),
when appropriate, and categorical data were summarized as
count (percentage). Student t-test and Wilcoxon signed-rank
test were used to test differences in continuous variables, when
appropriate, and the chi-square test and Fisher’s exact test were
used for proportions, when appropriate. Statistical analyses
were performed with the statistical software SPSS (version 16).
Sample Size Calculation
The authors hypothesized that with the application of the
ERACS protocol, length of hospital stay would be reduced by
2 days, assuming an average length of stay of 7 days and an SD
of 4 days. 15
Group sample sizes of 50 and 50 achieved 80% power to
detect a difference of 2 between the null hypothesis that both
group means of the length of hospital stay are 7 days and the
alternative hypothesis that the mean length of stay of group 2 is 5
days with known group SDs of 4 and 4 and with a signiﬁcance
level (alpha) of 0.05 using a 1-sided 2-sample t-test.
RESULTS
Patients’ Demographics and Perioperative Techniques
Overall, 105 patients were included in the assessment: 53
consecutive patients in the pre-ERACS group and 52
consecutive patients in the ERACS group after implementation
of the ERACS protocol.
Both groups were very similar and matched with respect to
age, sex, ethnicity, body mass index, smoking habit, and
premorbid status (Tables 2 and 3). In addition, surgery type,
cardiopulmonary bypass times, cross-clamp times, and anes-
thetic techniques were similar in both groups (Tables 4 and 5).
Perioperative Outcome Variables
Whereas length of hospital stay of 6 days remained
unchanged in the ERACS group (p = 0.31; Table 6), the total
number of patients with postoperative complications (including
hospital-acquired infections, AKI, atrial ﬁbrillation, respiratory
failure, cardiac tamponade, and postoperative myocardial
infarction) was signiﬁcantly smaller in the ERACS group
(po 0.01; see Table 6). Two patients in the pre-ERACS
group (1 who underwent CABG surgery and AVR and the
other CABG surgery) died after developing postoperative AKI
and subsequent sepsis, and multiorgan failure, respectively.
One patient in the ERACS group who underwent CABG and
AVR surgery died after postoperative AKI, subsequent sepsis,
and multiorgan failure.
As expected, the preoperative fasting times for ﬂuids in the
ERACS group were signiﬁcantly reduced by about 8 hours
compared with the control group (po 0.001; Table 7), and
preoperative fasting for solid food was similar.
The time to resumption of solid food intake was signiﬁ-
cantly shorter in the ERACS group, with 80% of patients
starting on postoperative day 1 versus only 55% in the pre-
ERACS group (p ¼ 0.007; Table 8). Resumption of post-
operative enteral ﬂuid intake and return of bowel function were
similar in both groups (see Table 8).
Postoperative pain scores throughout postoperative days 1
to 3 were signiﬁcantly lower in the ERACS group (Table 9),
and postoperative morphine infusions were administered for a
signiﬁcantly shorter period in the ERACS group (po 0.01; see
Table 9).
Signiﬁcantly fewer patients in the ERACS group com-
plained of postoperative nausea on day 3 (Table 10).
Table 1. Detailed Protocol for Enhanced Recovery After Cardiac
Surgery With Preoperative and Postoperative Bundles
Preoperative Bundle
 Preoperative assessment clinic including detailed patient
information about anesthesia and perioperative ﬂuid intake
 Evening before surgery: carbohydrate drink, 2 to 4  200 mL
 On the day of surgery:
○ Clear ﬂuids and clear carbohydrate drink, 2  200 mL until 2
hours preoperatively12,13
○ Gabapentin, 600 mg PO preoperatively14
Postoperative Bundle
 Opioid (morphine) infusion discontinued after extubation
 Regular intravenous ondansetron for ﬁrst 48 hr postoperatively
 Analgesia after extubation: regular paracetamol and codeine with
additional oral solution of morphine sulfate, if needed
 Lactulose 15 mL (10 g) twice daily, until opening of bowels
 Early postoperative mobilization (eg, sitting regularly in a chair
from the ﬁrst postoperative morning onwards)
Table 2. Patient Demographics
Pre-ERACS (n ¼ 53) ERACS (n ¼ 52) p Value
Age 66.5 (11.8) 68.6 (11.1) 0.34
Sex 0.87
Male 38 (71.7%) 38 (73.1%)
Female 15 (28.3%) 14 (26.9%)
Ethnicity 0.68
Caucasian 45 (85%) 43 (82.7%)
Asian 6 (11.3%) 5 (9.6%)
African 2 (3.7%) 4 (7.7%)
BMI (mean [kg/m2]) 26.9 (4.38) 24.3 (4.32) 0.45
Smoking 16 (30.2%) 12 (23.1%) 0.41
NOTE. Data are expressed as mean (standard deviation) or num-
ber (%).
Abbreviations: ERACS, enhanced recovery after cardiac surgery;
BMI, body mass index.
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DISCUSSION
This study suggested that an enhanced recovery protocol in
patients undergoing cardiac surgery (ERACS) is feasible and
potentially beneﬁcial for patients. The perioperative quality
improvement bundles in this ERACS pilot study were based on
previous evidence-based enhanced recovery protocols, includ-
ing avoidance of prolonged fasting periods preoperatively,
preoperative carbohydrate beverages, optimization of analgesia
with avoidance of long-acting opioids, prevention and treat-
ment of postoperative nausea and vomiting, early enteral
nutrition postoperatively, and early mobilization.
Transition from existing care to a perioperative bundle of
enhanced recovery interventions is not straightforward. Success
from enhanced recovery depends on delivery of all intended
interventions by all members of a multidisciplinary team at all
points during the pathway. This extends from initial outpatient
assessments through to eventual discharge. Organization of a
service to enable consistent implementation of timely, coordi-
nated interventions requires that certain fundamentals are met,
including stafﬁng levels, training, resource allocation, and full
engagement with the ethos of enhanced recovery by all
stakeholders. In addition, infrastructure for this comprehensive
service must include appropriate safeguards and clinical
governance. This trial demonstrated the feasibility of preoper-
ative and postoperative enhanced recovery bundles, which were
introduced through educating perioperative care teams, result-
ing in signiﬁcantly reduced preoperative fasting times for
liquids, earlier intake of solid food postoperatively, and
improved postoperative analgesia.
The evidence base at present does not allow for determi-
nation of the comparative importance of individual components
of this protocol. Protocols are subject to local interpretation,
preferences, and ﬁnancial circumstances. Consequently, certain
interventions may be omitted and the full beneﬁt of enhanced
recovery may not be realized.
It is known that a pathway for fast-track cardiac care
reduces time to extubation and length of stay in the intensive
care unit.16 One study prospectively evaluated the economic
impact of a “fast-track” strategy to cardiac surgery compared
with conventional recovery.17 The “fast-track” group (n ¼ 84)
demonstrated cost-effectiveness (mean saving per patient £371)
through a reduced duration of postoperative tracheal intubation
and critical care unit stays compared with the conventional
recovery group (n ¼ 52). However, total hospital length of stay
and rates of complications, reintubation, and readmission were
similar between the groups.
Table 3. Premorbid Status
Pre-ERACS
(n ¼ 53)
ERACS
(n ¼ 52)
p
Value
NYHA class of heart failure 2.2 (0.5) 2.2 (0.5) 0.79
CCS grading of angina pectoris 2.0 (0.7) 2.2 (0.5) 0.26
EuroSCORE (mean) SD 5.5 (4.0) 5.0 (3.2) 0.46
LV function 0.82
Normal 34 (64%) 35 (67%)
Impaired 11 (21%) 14 (27%)
Poor 8 (15%) 3 (6%)
Diabetes 0.55
NIDDM 6 (11%) 10 (19.2%)
IDDM 2 (3.7%) 1 (1.9%)
Receiving medical treatment for
hypertension
36 (67.9%) 30 (57.7%) 0.27
Previous MI 19 (35.8%) 22 (42.3%) 0.5
Hypercholesterolemia 30 (56.6%) 33 (63.5%) 0.47
COPD 5 (9.4%) 6 (11.5%) 0.72
PONV 1 (1.9%) 4 (7.8%) 0.16
NOTE. Data are expressed as mean (standard deviation) or num-
ber (%).
Abbreviations: ERACS, enhanced recovery after cardiac surgery;
NYHA, New York Heart Association; CCS, Canadian Cardiovascular
Society; LV, left ventricular; NIDDM, noninsulin–dependent diabetes
mellitus; IDDM, insulin–dependent diabetes mellitus; MI, myocardial
infarction; COPD, chronic obstructive pulmonary disease, requiring
treatment; PONV, known history of postoperative nausea and
vomiting.
Table 4. Surgical Variables
Pre-ERACS (n ¼ 53) ERACS (n ¼ 52) p Value
Surgery 0.71
CABG 31 (58.5%) 30 (57.7%)
CABG þ AVR 5 (9.4%) 3 (5.8%)
CABG þ MVR 1 (1.9%) 1 (1.9%)
AVR 8 (15.1%) 5 (9.6%)
MVR 3 (5.7%) 7 (13.5%)
Other 5 (9.4%) 6 (11.5%)
CPB (time [min]) 101.6 (38.1) 89.6 (29.7) 0.11
Cross-clamp (time [min]) 60.7 (31.8) 58.4 (21.6) 0.63
NOTE. Data are expressed as mean (standard deviation) or num-
ber (%).
Abbreviations: ERACS, enhanced recovery after cardiac surgery;
CABG, coronary artery bypass graft; AVR, aortic valve replacement;
MVR, mitral valve replacement; CPB, cardiopulmonary bypass.
Table 5. Anesthetic Variables
Pre-ERACS
(n ¼ 53)
ERACS
(n ¼ 52)
p
Value
Maintenance of anesthesia 0.76
Volatile 11 (20.7%) 18 (34.6%)
TIVA 9 (17%) 7 (13.5%)
TIVA þ volatile 33 (62.3%) 25 (48.1%)
Analgesia
Fentanyl 39 (73.6%) 46 (88.5%) 0.05
Morphine 36 (67.9%) 44 (84.6%) 0.05
Remifentanil 23 (43.4%) 21 (40.4%) 0.75
Inotropes
Norepinephrine 25 (47.2%) 25 (48.1%) 0.93
Dobutamine 1 (1.9%) 2 (3.8%) 0.55
Milrinone 2 (3.8%) 4 (7.7%) 0.39
Epinephrine 0 (0%) 3 (5.8%) 0.08
Insulin 19 (35.8%) 18 (34.6%) 0.89
Last temperature in operating
room (1C)
35.5 (0.69) 35.7 (0.56) 0.15
NOTE. Data are expressed as mean (standard deviation) or num-
ber (%).
Abbreviations: ERACS, enhanced recovery after cardiac surgery;
TIVA, total intravenous anesthesia
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Many interventions explicit in ERAS protocols are not
features of fast-track cardiac care pathways and are thus
inconsistently applied. If such ERAS components are bundled
and made explicit through an enhanced recovery cardiac care
package as in the proposed ERACS protocol presented here,
this may help improve outcome.
Although application of ERAS principles to cardiac surgery
is appealing, to date implementation has been limited. Clear
differences exist in the patient populations and the nature of the
surgery among patients undergoing gastrointestinal surgery (for
which ERAS is based) and patients undergoing cardiac surgery
(eg, bowel manipulation leading to postoperative ileus, pres-
ence/absence of cardiopulmonary bypass, bleeding risk).
Devising a pathway for cardiac surgery requires the integration
of selected, validated components of existing ERAS pathways
into interventions established in cardiac patients, as in the
proposed ERACS protocol presented here.
Interestingly these results revealed that postoperative pain
scores were signiﬁcantly lower in the ERACS group despite
shorter periods of postoperative morphine infusions. This may
have been due to greater awareness of and importance of
individual components of enhanced recovery pathways by the
medical teams caring for patients and also to additional
preoperative gabapentin doses or increased use of intraoper-
ative fentanyl and morphine in the ERACS group. The
incidence of postoperative chronic pain was not assessed;
however, improved postoperative pain might have beneﬁcial
effects on the incidence of chronic pain.
Because the cardiac patients were quite homogenoeus and
there were no statistically signiﬁcant differences in the baseline
characteristics between the 2 cohorts, they can be regarded as
matched in this study. Thus, propensity score matching was
unnecessary, and straightforward comparisons of means and
proportions on postoperative variables were sufﬁcient. Because
this was the nature of the study data, the authors do not believe
this to be a limitation of the study.
Table 6. Postoperative Complications and Length of Stay
Pre-ERACS
(n ¼ 53)
ERACS
(n ¼ 52)
p
Value
Number of patients with 1 or more
postoperative complications
27 (50.9%) 10 (19.2%) o0.01
Individual postoperative
complications
Postoperative infection* 4 (7.5%) 1 (1.9%) 0.36
AKI 6 (7.5%) 2 (3.8%) 0.27
AF 15 (28.3%) 7 (13.5%) 0.06
Respiratory failure† 5 (9.4%) 1 (1.9%) 0.10
MI‡ 2 (3.8%) 0 (0%) 0.16
Stroke§ 2 (3.8%) 0 (0%) 0.16
Death 2 (3.8%) 1 (1.9%) 0.57
Duration of hospital stay (days),
median (IQR)
6 (5-9) 6 (4-7) 0.31
NOTE. Values expressed as mean (standard deviation), number
(%), or median and interquartile range.
Abbreviations: ERACS, enhanced recovery after cardiac surgery;
AKI, acute kidney injury (raised creatinine of more than 30% from
preoperative level); AF, atrial ﬁbrillation requiring medical treatment;
MI, myocardial infarction.
*Postoperative infection: Hospital-acquired infection or sepsis
requiring prolonged postoperative antibiotics for more than 3 post-
operative days, including surgical site infections or respiratory tract
infections accompanied by prolonged increased white cell count or C-
reactive protein levels that require microbiologic review.
†Respiratory failure: New postoperative requirement of oxygen via
face mask or of noninvasive or invasive respiratory support.
‡MI (myocardial infarction): new pathologic Q-waves or new left
bundle-branch block in the electrocardiogram, or angiographically
documented new graft or native coronary artery occlusion, or
imaging evidence of new loss of viable myocardium plus biomarker
values above 5 times the 99th percentile of the normal reference
range).
§Stroke: New neurologic deﬁcit.
Table 7. Preoperative Fasting Times
Pre-ERACS (n ¼ 53) ERACS (n ¼ 52) p value
Fasting
Liquids 12.25 (7.24) 4.18 (3.47) o0.001
Solids 14.6 (6.91) 13.35 (3.16) 0.28
NOTE. Data are expressed as mean (standard deviation).
Abbreviations: ERACS, enhanced recovery after cardiac surgery.
Table 8. Postoperative Gastrointestinal Outcome Variables
Pre-ERACS
(n ¼ 53)
ERACS
(n ¼ 52)
p
Value
First postoperative intake of
enteral solids
Day 1 29 (54.7%) 42 (80.1%) 0.007
Day 2 39 (73.5%) 47 (90.3%) 0.04
Day 3 47 (88.7%) 51 (98%) 0.13
First postoperative intake of
enteral liquids
Day 1 48 (90.5%) 50 (96%) 0.35
Day 2 50 (94.3%) 51 (98%) 0.62
Day 3 51 (96.2%) 52 (100%) 0.50
Bowel opening
Day 1 3 (5.8%) 0 (0%) 0.15
Day 2 13 (24.5%) 12 (23%) 0.804
Day 3 30 (56.6%) 35 (67.3%) 0.415
NOTE. Data are expressed as number (%).
Abbreviation: ERACS, enhanced recovery after cardiac surgery.
Table 9. Postoperative Pain Scores at Rest and Opioid Infusions
Pre-ERACS (n ¼ 53) ERACS (n ¼ 52) p value
Pain (0-3)*
Day 1 1.7 (0.9) 1.1 (0.9) o0.01
Day 2 1.3 (0.8) 0.9 (0.6) o0.05
Day 3 0.9 (0.8) 0.4 (0.7) o0.01
Opioid infusion
Morphine 52 (94.3%) 50 (96.2%) 0.62
Fentanyl 1 (1.9%) 2 (3.8%)
Duration (days) 3 (2-3) 0 (0-0) o0.01
NOTE. Data are expressed as mean (standard deviation), number
(%), or median and interquartile range.
Abbreviations: ERACS, enhanced recovery after cardiac surgery;
SD, standard deviation.
* 0, no pain; 1, mild pain; 2, moderate pain; 3, severe pain.
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Study Limitations
The authors have not conducted an ERACS as a proof-of-
concept randomized controlled trial. Feasibility of implementation
of quality improvement bundles, however, probably is greater in
groups of patients grouped by perioperative teams rather than in
individual patients only. Therefore, a successful implementation is
more likely in a cohort over time than in individual patients. A
multicenter trial design with cluster randomization would be a
possible next step for a proof-of-concept trial. This would confer
the advantage of larger numbers of patients and greater statistical
power for assessments of clinically signiﬁcant improvements of
single postoperative outcome variables.
In addition, formal perioperative ﬂuid management or goal-
directed therapy (GDT) based on pulmonary artery catheter or
esophageal Doppler measurements were not included in this
pilot study. Nevertheless, intraoperatively, preload was opti-
mized in both groups according to regular transesophageal
echocardiographic assessments in the majority of patients,
which included the left and right ventricular ﬁlling status.
Recently, a meta-analysis demonstrated that GDT in cardiac
surgery had the potential to reduce postoperative morbidity and
length of hospital stay, but not mortality.18 Therefore, whether
outcomes might be further improved with a formal postoper-
ative (nurse-led) GDT protocol remains open.
This study demonstrated a neutral result regarding length of
hospital stay. Future trials are necessary to assess whether
potentially improved postoperative morbidity with ERACS also
is associated with a reduced length of stay and thus potentially
improved costs.
Apart from the perioperative outcomes assessed in this pilot
study, additional variables in future studies also could include
patient satisfaction scores, readmission rates to the intensive
care unit, quality-of-life assessments, disability-free survival,19
and longer follow-ups.
This pilot study demonstrated feasibility and the potential
for improved postoperative morbidity with the implementation
of an enhanced recovery bundle of interventions in patients
undergoing cardiac surgery.
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Table 10. Number of Patients Complaining of Postoperative Nausea
and Vomiting
Pre-ERACS (n ¼ 53) ERACS (n ¼ 52) p value
Nausea
Day 1 26 (49%) 22 (42.3%) 0.42
Day 2 20 (37.7%) 11 (21.1%) 0.71
Day 3 22 (41.5%) 9 (17.3%) o0.05
Vomiting
Day 1 14 (26.4%) 12 (23.1%) 0.62
Day 2 7 (13.2%) 4 (7.7%) 0.26
Day 3 5 (9.4%) 1 (1.9%) 0.24
NOTE. Data are expressed as number (%).
Abbreviation: ERACS, enhanced recovery after cardiac surgery.
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